Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.
about
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Discovery of N-{3-[
@nl
Discovery of N-{3-[(ethanimido ...... e therapy of malignant glioma.
@en
type
label
Discovery of N-{3-[
@nl
Discovery of N-{3-[(ethanimido ...... e therapy of malignant glioma.
@en
prefLabel
Discovery of N-{3-[
@nl
Discovery of N-{3-[(ethanimido ...... e therapy of malignant glioma.
@en
P2093
P50
P1476
Discovery of N-{3-[(ethanimido ...... e therapy of malignant glioma.
@en
P2093
Amelia Cataldi
Barbara De Filippis
Cristina Maccallini
Maria A Potenza
Marialuigia Fantacuzzi
Mauro Di Matteo
Nazzareno Re
Pasquale Amoia
Rosa Amoroso
Sara Di Silvestre
P356
10.1016/J.EJMECH.2018.04.027
P577
2018-04-13T00:00:00Z